Why are the risks of hypoglycemia very low when using the fixed ratio, combination regimens? Does this have to do with slow titration or mechanistic complementarity?

Why are the risks of hypoglycemia very low when using the fixed ratio, combination regimens? Does this have to do with slow titration or mechanistic complementarity?

Why are the risks of hypoglycemia very low when using the fixed ratio, combination regimens? Does this have to do with slow titration or mechanistic complementarity? By what mechanism do they mitigate hypoglycemic risk?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Robert Henry, MD

Robert Henry, MD

Chief, Center for Metabolic Research Chief, Section of Endocrinology, Metabolism & Diabetes Veterans Affairs Healthcare System Professor of Medicine‚ Department of Medicine Division of Endocrinology and Metabolism University of California‚ San Diego